跳至主要内容
临床试验/KCT0005278
KCT0005278尚未招募未知

Evaluation of efficacy and safety of terazosin in patients with benign prostatic hyperplasia with lower urinary tract symptoms

Yonsei University, Wonju Severance Christian Hospital0 个研究点目标入组 174 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
174

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
40(Year) 至 o Limit(—)
性别
Male

入选标准

  • (1) Male over 40 years old
  • (2) A person with an IPSS total score of 8 or higher
  • (3) Those whose maximum urine velocity (Qmax) is less than 10mL/s
  • (4) Those who have a single void volume of 150 mL or more
  • (5) A person who consented to participate in this study by handwritten signature

排除标准

  • (1) People who are hypersensitive to Alpha-blocker drugs
  • (2) People with bladder neck stenosis and urinary tract stenosis
  • (3) Those with renal dysfunction (creatinine concentration in serum>2.0mg/dL)
  • (4) People who have a severe liver disorder or have a history
  • (5) People with severe cardiovascular disease
  • (6) People with severe hypotension
  • (7) Other research directors judge that it is inappropriate to participate in this research

研究者

发起方
Yonsei University, Wonju Severance Christian Hospital

相似试验